U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Forman-Hoffman V, Middleton JC, Feltner C, et al. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. (Comparative Effectiveness Review, No. 207.)

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update

Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].

Show details

Table 18Characteristics of included placebo-controlled trials of alpha-blockers

StudyArm Dose mg/Day (N)Duration (Weeks)Population Trauma TypeBaseline PTSD SeverityaMean Age (Y)% Female% Non-whiteRisk of Bias
Raskind et al., 200374Prazosin 2 to 10 mg (5)
Placebo (5)
20Male
Combat veterans
79.1 to 83.6530NRMedium
Raskind et al., 200775Prazosin 2 to 15 mg (20)
Placebo (20)
8Male and female
Combat veterans
70.056535Medium
Raskind et al., 201376Prazosin 1 mg titrated to a max of 20 mg for men or 10 mg for women (32)
Placebo (35)
15Veterans Active-duty soldiers, Combat trauma77.3 to 85.7301537Medium
a

Data reported are mean CAPS or range of mean CAPS scores across groups unless otherwise specified.

Note: When mean data for baseline PTSD severity were not reported for the total sample but were presented for each study arm, we provide the range across arms.

CAPS = Clinician-Administered PTSD Scale; F = female; mg = milligram; N = total number randomized/assigned to intervention and control groups; NR = not reported; PTSD = posttraumatic stress disorder; y = year.

Views

  • Cite this Page
  • PDF version of this title (6.4M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...